Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease
Case Reports in Hepatology · 2012
DOI: 10.1155/2012/209258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Hepatology, 2012. Verfasst von John P Knorr und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Einstein Medical Center Philadelphia, 5501 Old York Road, Philadelphia, PA 19141, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Purpose
Metronidazole-induced encephalopathy (MIE) has been rarely reported. We report a case in a patient with end-stage liver disease (ESLD). Summary . A 63-year-old male with ESLD secondary to hepatitis C virus presented with progressively worsening fatigue, slurred speech, aphasia, vomiting, and left-sided facial droop after completing a 2-week course of metronidazole for recurrent Clostridium difficile -associated diarrhea. He completed a previous course of metronidazole 3 weeks prior to presentation. He is on the liver transplant waiting list and has known hepatic encephalopathy. MRI revealed hyperintense T2 signals involving the bilateral dentate nuclei, inferior colliculi and splenium of the corpus callosum, and increased diffusion restriction at the splenium of the corpus callosum. His neurological function improved over the next several days. He underwent liver transplantation 6 days after admission. A follow-up MRI 6 weeks after presentation revealed resolution of abnormalities; however, paresthesias persisted 6 months after MIE diagnosis.
Conclusion
An ESLD patient with hepatic encephalopathy developed MIE after a relatively short course of metronidazole. Metronidazole has been shown to accumulate in patients with ESLD. Increased awareness for neurotoxicity when using metronidazole in ESLD patients is warranted, especially in those with potentially confounding hepatic encephalopathy.
Autor:innen und Institutionen
- Department of Pharmacy, Einstein Medical Center Philadelphia, 5501 Old York Road, Philadelphia, PA 19141, USA.
- Department of Transplant Surgery, Einstein Medical Center Philadelphia, Philadelphia, PA 19141, USA.
- Department of Hepatology, Einstein Medical Center Philadelphia, Philadelphia, PA 19141, USA.
- Department of Radiology, Einstein Medical Center Philadelphia, Philadelphia, PA 19141, USA.
Zitieren
APA
Knorr, J. P., Javed, I., Sahni, N., Cankurtaran, C. Z., & Ortiz, J. A. (2012). Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease. Case Reports in Hepatology. https://doi.org/10.1155/2012/209258
Vancouver
Knorr JP, Javed I, Sahni N, Cankurtaran CZ, Ortiz JA. Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease. Case Reports in Hepatology. 2012. doi:10.1155/2012/209258
BibTeX
@article{Knorr2012,
author = {Knorr, John P and Javed, Imran and Sahni, Neha and Cankurtaran, Ceylan Z and Ortiz, Jorge A},
title = {Metronidazole-Induced Encephalopathy in a Patient with End-Stage Liver Disease},
journal = {Case Reports in Hepatology},
year = {2012},
doi = {10.1155/2012/209258}
}
EUVIMED